Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma-Reference-Cited by-同舟云学术

Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma

Published:2012-02 Issue:2 Volume:255 Page:357-362
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Hoshimoto Sojun,Faries Mark B.,Morton Donald L.,Shingai Tatsushi,Kuo Christine,Wang He-jing,Elashoff Robert,Mozzillo Nicola,Kelley Mark C.,Thompson John F.,Lee Jeffrey E.,Hoon Dave S. B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference31 articles.

1. Prognostic factors in 1,521 melanoma patients with distant metastases.;Barth;J Am Coll Surg,1995

2. Complete metastasectomy in patients with stage IV metastatic melanoma.;Ollila;Lancet Oncol,2006

3. Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma.;Ollila;J Surg Oncol,1998

4. Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma.;Mocellin;Int J Cancer,2004

5. The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis.;Mocellin;Clin Cancer Res,2006

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor cells: from new biological insights to clinical practice;Signal Transduction and Targeted Therapy;2024-09-02

2. Biomarkers of minimal residual disease and treatment;Advances in Clinical Chemistry;2024

3. Plasma extracellular vesicle long RNAs predict response to neoadjuvant immunotherapy and survival in patients with non‐small cell lung cancer;Pharmacological Research;2023-10

4. Liquid Biopsies, Novel Approaches and Future Directions;Cancers;2023-03-03

5. Circulating Tumour Cells in Solid Cancer;Current Cancer Biomarkers;2023-01